GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HEXO Corp (FRA:74H) » Definitions » Research & Development

HEXO (FRA:74H) Research & Development : €0.59 Mil (TTM As of Apr. 2023)


View and export this data going back to 2017. Start your Free Trial

What is HEXO Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. HEXO's Research & Development for the three months ended in Apr. 2023 was €0.06 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2023 was €0.59 Mil.

HEXO Research & Development Historical Data

The historical data trend for HEXO's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HEXO Research & Development Chart

HEXO Annual Data
Trend Sep14 Sep15 Sep16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Research & Development
Get a 7-Day Free Trial Premium Member Only - 1.92 2.99 2.59 2.44

HEXO Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.18 0.24 0.12 0.06

HEXO Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HEXO  (FRA:74H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

HEXO Research & Development Related Terms

Thank you for viewing the detailed overview of HEXO's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

HEXO Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HEXO Corp (FRA:74H) » Definitions » Research & Development
Comparable Companies
NEOE:GRAM.U XCNQ:INNO XCNQ:BHSC XCNQ:MMEN XCNQ:ACRG.A.U XCNQ:RVV XCNQ:GWAY XCNQ:RIV TSX:XLY XCNQ:BILZ XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
120 de la Rive Road, Gatineau, QC, CAN, J8M 1V2
Website
https://www.hexocorp.com
HEXO Corp is engaged in producing and selling cannabis and cannabis products. The company is focused on smoke-free and traditional cannabis products. The firm's products include dried flowers, oils, and vapes. It generates its revenue from various sources such as Beverage Based Adult-Use Sales, Medical, Wholesale and International sales.

HEXO Headlines

No Headlines